189
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Steroidogenic factor-1 (SF-1, NR5A1) and human disease

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Steroidogenic factor-1 (SF-1, Ad4BP, encoded by NR5A1) is a key regulator of adrenal and reproductive development and function. Based upon the features found in Nr5a1 null mice, initial attempts to identify SF-1 changes in humans focused on those rare individuals with primary adrenal failure, a 46,XY karyotype, complete gonadal dysgenesis and Müllerian structures. Although alterations affecting DNA-binding of SF-1 were found in two such cases, disruption of SF-1 is not commonly found in patients with adrenal failure. In contrast, it is emerging that variations in SF-1 can be found in association with a range of human reproductive phenotypes such as 46,XY disorders of sex development (DSD), hypospadias, anorchia, male factor infertility, or primary ovarian insufficiency in women. Overexpression or overactivity of SF-1 is also reported in some adrenal tumors or endometriosis. Therefore, the clinical spectrum of phenotypes associated with variations in SF-1 is expanding and the importance of this nuclear receptor in human endocrine disease is now firmly established.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation.

          Studies in adrenocortical cells have implicated the orphan nuclear receptor SF-1 in the gene regulation of the steroid hydroxylases. We used targeted disruption of the Ftz-F1 gene, which encodes SF-1, to examine its role in intact mice. Despite normal survival in utero, all Ftz-F1 null animals died by postnatal day 8; these animals lacked adrenal glands and gonads and were severely deficient in corticosterone, supporting adrenocortical insufficiency as the probable cause of death. Male and female Ftz-F1 null mice had female internal genitalia, despite complete gonadal agenesis. These studies establish that the Ftz-F1 gene is essential for sexual differentiation and formation of the primary steroidogenic tissues.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Determinants of target gene specificity for steroid/thyroid hormone receptors.

            The molecular specificity of the receptors for steroid and thyroid hormones is achieved by their selective interaction with DNA binding sites referred to as hormone response elements (HREs). HREs can differ in primary nucleotide sequence as well as in the spacing of their dyadic half-sites. The target gene specificity of the glucocorticoid receptor can be converted to that of the estrogen receptor by changing three amino acids clustered in the first zinc finger. Remarkably, a single Gly to Glu change in this region produces a receptor that recognizes both glucocorticoid and estrogen response elements. Further replacement of five amino acids in the stem of the second zinc finger transforms the specificity to that of the thyroid hormone receptor. These findings localize structural determinants required for discrimination of HRE sequence and half-site spacing, respectively, and suggest a simple pathway for the coevolution of receptor DNA binding domains and hormone-responsive gene networks.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Steroidogenic factor 1: a key determinant of endocrine development and function.

                Bookmark

                Author and article information

                Journal
                Mol Cell Endocrinol
                Mol. Cell. Endocrinol
                Molecular and Cellular Endocrinology
                North Holland Publishing
                0303-7207
                1872-8057
                10 April 2011
                10 April 2011
                : 336
                : 1-2
                : 198-205
                Affiliations
                Developmental Endocrinology Research Group, Clinical & Molecular Genetics Unit, UCL Institute of Child Health, University College London, London WC1N 1EH, United Kingdom
                Author notes
                [* ]Corresponding author at: Developmental Endocrinology Research Group, Clinical & Molecular Genetics Unit, UCL Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK. Tel.: +44 207 905 2887; fax: +44 207 404 6191. j.achermann@ 123456ich.ucl.ac.uk
                Article
                MCE7676
                10.1016/j.mce.2010.11.006
                3057017
                21078366
                0fcba89e-005e-4c0e-8e50-545e22b63136
                © 2011 Elsevier Ireland Ltd.

                This document may be redistributed and reused, subject to certain conditions.

                History
                : 22 October 2010
                : 4 November 2010
                : 4 November 2010
                Categories
                Review

                Endocrinology & Diabetes
                amh, anti-müllerian hormone (also known as müllerian-inhibiting substance),endometriosis,lbd, ligand-binding domain,infertility,poi, primary ovarian insufficiency,primary ovarian insufficiency (poi),adrenocortical tumor,act, adrenocortical tumor,steroidogenic factor-1 (sf-1),dbd, dna-binding domain,nr5a1,46,xy disorders of sex development (dsd),adrenal failure,dsd, disorders of sex development

                Comments

                Comment on this article